| pubmed-article:17574519 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C0004057 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C0005821 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C0010286 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C1948041 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C1305957 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C0205322 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
| pubmed-article:17574519 | lifeskim:mentions | umls-concept:C0439608 | lld:lifeskim |
| pubmed-article:17574519 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17574519 | pubmed:dateCreated | 2008-5-29 | lld:pubmed |
| pubmed-article:17574519 | pubmed:abstractText | Creatinine kinase-MB (CK-MB) and cardiac troponin I (cTnI) elevations are highly specific for myonecrosis after percutaneous coronary intervention (PCI). Aspirin is used to prevent thrombotic complications. Several studies have shown that some individuals exhibit a reduced or completely missing antiplatelet response to aspirin. The aim of this study is to investigate the effects of platelet reactivity despite aspirin therapy on CK-MB and cTnI levels after elective percutaneous coronary interventions despite 600 mg loading dose of clopidogrel. | lld:pubmed |
| pubmed-article:17574519 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17574519 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17574519 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17574519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17574519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17574519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17574519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17574519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17574519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17574519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17574519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17574519 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17574519 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17574519 | pubmed:issn | 0929-5305 | lld:pubmed |
| pubmed-article:17574519 | pubmed:author | pubmed-author:YildirirAylin... | lld:pubmed |
| pubmed-article:17574519 | pubmed:author | pubmed-author:AydinalpAlpA | lld:pubmed |
| pubmed-article:17574519 | pubmed:author | pubmed-author:MuderrisogluH... | lld:pubmed |
| pubmed-article:17574519 | pubmed:author | pubmed-author:OzinBulentB | lld:pubmed |
| pubmed-article:17574519 | pubmed:author | pubmed-author:GulmezOykuO | lld:pubmed |
| pubmed-article:17574519 | pubmed:author | pubmed-author:KaynarGamzeG | lld:pubmed |
| pubmed-article:17574519 | pubmed:author | pubmed-author:ErtanCagatayC | lld:pubmed |
| pubmed-article:17574519 | pubmed:author | pubmed-author:KonasDidemD | lld:pubmed |
| pubmed-article:17574519 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17574519 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:17574519 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17574519 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17574519 | pubmed:pagination | 239-46 | lld:pubmed |
| pubmed-article:17574519 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:meshHeading | pubmed-meshheading:17574519... | lld:pubmed |
| pubmed-article:17574519 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:17574519 | pubmed:articleTitle | Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions. | lld:pubmed |
| pubmed-article:17574519 | pubmed:affiliation | Department of Cardiology, Baskent University Faculty of Medicine, Ankara, Turkey. gulmezoyku@yahoo.com | lld:pubmed |
| pubmed-article:17574519 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17574519 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| entrez-gene:7137 | entrezgene:pubmed | pubmed-article:17574519 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17574519 | lld:entrezgene |
